Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease
about
Glucose-6-phosphate dehydrogenase-deficient mice have increased renal oxidative stress and increased albuminuria.Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilationElevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial.Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP)Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA)Inverse relationship between the inflammatory marker pentraxin-3, fat body mass, and abdominal obesity in end-stage renal diseaseBiomarkers of chronic inflammatory state in uremia and cardiovascular disease.Adding thiazide to a rennin-angiotensin blocker regimen to improve left ventricular relaxation in diabetes and nondiabetes patients with hypertension.Analysis of Clinically Relevant Factors for Pulmonary Hypertension in Maintenance Hemodialysis Patients.Host-protective effect of circulating pentraxin 3 (PTX3) and complex formation with neutrophil extracellular traps.Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.Relationship between Plasma Pentraxin-3, Neutrophil-to-Lymphocyte Ratio, and Atherosclerosis in Renal Transplant Patients.Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.Long pentraxin 3: experimental and clinical relevance in cardiovascular diseasesEffect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuriaDetection of Occult Acute Kidney Injury in Glucose-6-Phosphate Dehydrogenase Deficiency AnemiaEvaluation of the association of plasma pentraxin 3 levels with type 2 diabetes and diabetic nephropathy in a Malay populationSoluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients.The biocontaminants and complexity of damp indoor spaces: more than what meets the eyes.Association of Pentraxin 3 Gene Polymorphisms with Susceptibility to Diabetic Nephropathy.Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications.Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease.The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules.Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation.Pentraxins in the activation and regulation of innate immunity.Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease.Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation.Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function.RNA-seq analysis provide new insights into mapk signaling of apolipoproteinciii-induced inflammation in porcine vascular endothelial cells.Reciprocal contribution of pentraxin 3 and C-reactive protein to obesity and metabolic syndrome.Pentraxin 3 as a novel early biomarker for the prediction of Henoch-Schönlein purpura nephritis in children.Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients.Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations.Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss.The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients.Plasma pentraxin3 and arterial stiffness in men with obstructive sleep apnea.The prevalence and association of chronic kidney disease and diabetes in liver cirrhosis using different estimated glomerular filtration rate equation.Relationship of pentraxin 3 with insulin sensitivity in gestational diabetes.
P2860
Q33613186-C7A1C39A-1D7F-45B0-91F5-F05EECBCA177Q33944773-7C6351F1-6CBE-4884-AAC0-1EB0C1519C25Q34713240-53235D20-20FB-48EC-A4E2-1EFEC7FE3A2BQ34751855-EF10C1D4-320A-4B8B-B858-9D05D563A924Q35140370-00914313-310C-43F5-8F0C-3610AC672943Q35612606-8D52626D-777E-4216-98FD-236D4C14910AQ35624204-1C721B88-77DB-45B5-9A64-4B81E7A61D53Q35664554-7E56F99A-4094-4048-B11D-9663A29CC864Q36026534-F5FDF537-7F50-4A89-9CAB-6DB59CAC088FQ36247067-9BA32970-C527-4030-A48E-6820DA5D12DAQ36420463-61708843-3D6A-4166-AFB1-CE1D67A1C692Q36463833-DA815BA8-6665-48F0-9C9E-10D6D39909AEQ36533057-01DE3DD2-89E6-434C-B55F-C3BDAD9DF666Q36551416-5CAE31C5-6519-456A-81C6-5764CD6D0A39Q36770925-CDE83CBD-053B-4CA4-BC5C-837B3745416DQ36830914-04CD14B3-62E3-4033-B4D8-D67D8D522145Q37123175-3242CD79-152C-4AC8-B8DF-B73AC16A9B7CQ37242212-09F8E60A-1623-4FC7-9D0F-F49CC1781BC8Q37370584-D0D19D27-948D-4FDC-ACCC-7C4BB8BE0F31Q37456616-E30C6B5D-B129-4234-AAEF-33AA3DD613EDQ37606127-F41DD80A-0F42-4640-A513-61C44DFFED96Q37621173-0EBACE07-D48F-42D3-91E8-2B73C7966B00Q38016491-818B5EDA-AEB6-4073-B237-0CC1E50D7995Q38084920-EFDAC2A7-1DCA-4D41-A527-B8CA0960E6A2Q38092832-3189EAB8-20BD-4ADB-851F-EFEC594EADA1Q38901060-00FCF788-B73C-410F-9FDC-3135F535D9CEQ38991073-16713731-3A2A-4E97-A6A7-ECC1DE4BF6EBQ39252622-01E94923-55B8-4CF9-8961-1999E9119BFBQ40161972-EACB3E85-DDB7-4B74-BCAD-8119F9E088B9Q40865321-51872B2C-1A60-4242-A97A-6D25598657A4Q42777805-BD6EA539-36BF-4A12-BE4B-52D2D0B5E2BAQ43181277-D35479A3-55FE-4440-81A1-FB3DC7A3EE9BQ43992427-ACAA6AD4-0DBB-4EC5-8E01-20F31D033857Q44456570-F2A00A74-1807-4B48-B7DB-F87E7C7AC168Q46071688-29CA8194-085A-457F-9AAD-DBB31F183B57Q46237239-BB0BCBDE-750F-4F98-B1EC-E786BF49F1E3Q47848978-2AB5C701-6EA6-4C64-BC22-D5FA5EC8B0CBQ48324307-FC8A775E-74C3-4BD6-B9BD-4CF8E044CD27Q49299108-77AF6678-D8BA-49AA-986C-CA5607CD83D4Q51345186-754FEEB8-B268-45F8-B4AB-A4035C2B5A59
P2860
Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Novel links between the long p ...... dvanced chronic kidney disease
@ast
Novel links between the long p ...... dvanced chronic kidney disease
@en
type
label
Novel links between the long p ...... dvanced chronic kidney disease
@ast
Novel links between the long p ...... dvanced chronic kidney disease
@en
prefLabel
Novel links between the long p ...... dvanced chronic kidney disease
@ast
Novel links between the long p ...... dvanced chronic kidney disease
@en
P2093
P2860
P50
P356
P1476
Novel links between the long p ...... dvanced chronic kidney disease
@en
P2093
Abdul Rashid Qureshi
Anders Alvestrand
Juan J Carrero
Mahmut I Yilmaz
Mengli Tong
Mohamed E Suliman
Mujdat Yenicesu
Mutlu Saglam
Osman M Ipcioglu
Peter Barany
P2860
P304
P356
10.2215/CJN.03960907
P577
2008-04-16T00:00:00Z